Atlas Trials

Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer

Clinical trial NCT02418247 · UNKNOWN

Trial details

NCT number
NCT02418247
Sponsor
National Cancer Center, Korea
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Thyroid Neoplasms
Start date
2013-05-01
Primary completion
2017-12-01
Enrollment
556

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.